- Home
- KLIC vs DYN Comparison
KLIC vs DYN Comparison
Compare KLIC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KLIC | DYN |
|---|---|---|
| Founded | 1951 | 1984 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.4B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | KLIC | DYN |
|---|---|---|
| Price | $57.47 | $17.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 17 |
| Target Price | ★ $52.67 | $39.94 |
| AVG Volume (30 Days) | 647.9K | ★ 2.1M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.42% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $654,081,000.00 | N/A |
| Revenue This Year | $21.00 | N/A |
| Revenue Next Year | $7.27 | N/A |
| P/E Ratio | $14,139.63 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.63 | $6.36 |
| 52 Week High | $60.00 | $25.00 |
Technical Indicators
Market Signals| Indicator | KLIC | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 65.64 | 46.83 |
| Support Level | $56.31 | $16.00 |
| Resistance Level | $60.00 | $18.32 |
| Average True Range (ATR) | 2.21 | 0.93 |
| MACD | 0.08 | 0.07 |
| Stochastic Oscillator | 69.00 | 46.92 |
Price Performance
Historical ComparisonAbout KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.